Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease

NCT05425771 is registered in ClinicalTrials.gov with Klinikum Garmisch-Patenkirchen as lead sponsor.

NCT NCT05425771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05425771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease
Lead sponsor
Klinikum Garmisch-Patenkirchen
Phase
Not applicable
Overall status
Unknown status
Start date
July 14, 2022
Completion date
May 31, 2023
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastro-esophageal reflux, reflux, gastroesophageal